<DOC>
<DOCNO>EP-0626950</DOCNO> 
<TEXT>
<INVENTION-TITLE>
TRIAZINE DERIVATES WITH UV-FILTER PROPERTIES
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K830	C07D25146	C07D25134	A61K800	C07D25170	A61K892	A61Q1704	A61K800	A61K892	A61K849	C07D25100	A61Q1704	C07D25152	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	C07D	C07D	A61K	C07D	A61K	A61Q	A61K	A61K	A61K	C07D	A61Q	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K8	C07D251	C07D251	A61K8	C07D251	A61K8	A61Q17	A61K8	A61K8	A61K8	C07D251	A61Q17	C07D251	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
CASUTT MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
HEYWANG ULRICH
</INVENTOR-NAME>
<INVENTOR-NAME>
MARTIN ROLAND
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHWARZ MICHAEL W
</INVENTOR-NAME>
<INVENTOR-NAME>
STEIN INGEBORG
</INVENTOR-NAME>
<INVENTOR-NAME>
CASUTT, MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
HEYWANG, ULRICH
</INVENTOR-NAME>
<INVENTOR-NAME>
MARTIN, ROLAND
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHWARZ, MICHAEL, W.
</INVENTOR-NAME>
<INVENTOR-NAME>
STEIN, INGEBORG
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Triazine derivatives of the formula I


wherein

Y
is NH or O,
R
1
is a radical of the formula II


wherein

Phe
is a phenylene group which is unsubstituted or
substituted by 1 to 4 alkyl or alkoxy groups having

1 to 10 C atoms

and

X
is H or -SO
3
H,

and

R
2
 and R
3
in each case independently of one another are a
radical of the formula Y-R
1
,

or

alkoxy, alkylamino having 1 to 10 C atoms,
arylamino or aryloxy having up to 10 C atoms,

but excepting compounds in each of which two of the
triazine substituents Y-R
1
, R
2
 or R
3
 are

Phe
is unsubstituted phenylene group
X
is H

and the third triazine substituent is alkoxy or
alkylamino having 8 to 10 C atoms.
Triazine derivatives of the formula I1 according
to Claim 1



wherein R
1
, R
2
 and Y have the meaning given,

but excepting compounds in which

Y-R
1
 is


where

Phe
is unsubstituted phenylene group
X
is H

and

R2
is alkoxy or alkylamino having 8 to 10 C atoms.
Triazine derivatives of the formula I2 according
to Claim 1



wherein

R
1
 and Y
have the meaning given and
R
2
 and R
3
in each case independently of one another are
alkoxy, alkylamino having 1 to 10 C atoms,

arylamino or aryloxy having up to 10 C atoms.
Triazine derivative according to Claim 1 or 2,
of the formula Ia 



wherein Phe is an unsubstituted 1,4-phenylene group and
X is H.
Triazine derivative according to one of Claims 1
to 4, wherein Y is NH.
Triazine derivative according to Claim 3 of the
formula Ic



wherein R
1
 has the meaning given and Alkyl is alkyl
having 1 to 10 C atoms.
Triazine derivative according to Claim 3 of the
formula Id



wherein R
1
 has the meaning given and Alkyl is alkyl
having 1 to 10 C atoms.
Process for the preparation of the compounds of
the formula Ic, 
characterized in that
 equimolar amounts
of cyanuric chloride and a compound of the formula IIa


R
1
NH
2

wherein R
1
 has the meaning given, are reacted with one
another at temperatures between 0Â°C and room

temperature, if appropriate in the presence of a weak
base, and the triazine derivative thereby formed, of

formula IIIa 


wherein R
1
 has the meaning given, is isolated and then
reacted with at least 2 mol of an alcohol.
Compound of the formula IIIa


wherein R
1
 has the meaning of a radical of the formula II


wherein

Phe
is a phenylene group which is unsubstituted or
substituted by 1 to 4 alkyl or alkoxy groups having

1 to 10 C atoms

and

X
is H or -SO
3
H,
Use of the compounds of the formula I according
to one of Claims 1 to 7 as a sun filter in the

wavelength range from 280 to 400 nm.
Cosmetic formulation, 
characterized in that
 it
comprises an active amount of at least one compound of

the formula I according to Claim 1 in a cosmetically
tolerated carrier.
Cosmetic formulation according to Claim 11,
wherein the carrier contains at least one fatty phase,


characterized in that
 it comprises at least one compound
of the formulae Ia, Ib, Ic or Id.
Cosmetic formulation according to one of Claims
11 to 12, 
characterized in that
 it comprises 0.1 to 10%
by weight, preferably 0.4 to 1.0% by weight, in particular

about 0.5% by weight, of at least one compound
of the formula I.
Use of the compounds of the formula I according 
to one of Claims 1 to 7 for producing a medicament.
Use according to Claim 14 for producing a
medicament for the preventive treatment of the skin

against inflammations and allergies.
</CLAIMS>
</TEXT>
</DOC>
